August 16, 2017 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Celgene Corporation, a stock transaction, valued at $15,001 - $50,000. The trade took place on August 16, 2017 and was disclosed on September 5, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.